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SUMMARY
MRE11 within the MRE11-RAD50-NBS1 (MRN) com-
plex acts in DNA double-strand break repair (DSBR),
detection, and signaling; yet, how its endo- and
exonuclease activities regulate DSBR by non-
homologous end-joining (NHEJ) versus homologous
recombination (HR) remains enigmatic. Here, we
employed structure-based design with a focused
chemical library to discover specific MRE11 endo-
or exonuclease inhibitors. With these inhibitors, we
examined repair pathway choice at DSBs generated
in G2 following radiation exposure. While nuclease
inhibition impairs radiation-induced replication pro-
tein A (RPA) chromatin binding, suggesting dimin-
ished resection, the inhibitors surprisingly direct
different repair outcomes. Endonuclease inhibition
promotes NHEJ in lieu of HR, while exonuclease inhi-
bition confers a repair defect. Collectively, the results
describe nuclease-specific MRE11 inhibitors, define
distinct nuclease roles in DSB repair, and support a
mechanism whereby MRE11 endonuclease initiates
resection, thereby licensing HR followed by MRE11
exonuclease and EXO1/BLM bidirectional resection
toward and away from the DNA end, which commits
to HR.
INTRODUCTION
MRE11 nuclease forms the core of the MRE11-RAD50-NBS1
(MRN) complex, which has essential roles in detecting, signaling,
protecting, and repairing DNA double-strand breaks (DSBs)
(Stracker and Petrini, 2011; Williams et al., 2007; Wyman and
Kanaar, 2006). As a first responder to DSBs, MRN promotes
appropriate repair by nonhomologous end-joining (NHEJ) or
homologous recombination (HR), playing essential roles via its
30-50 exonuclease and single-stranded (ss) and DNA hairpin
endonuclease activities (Lisby et al., 2004; Paull and Gellert,
1998; Stracker and Petrini, 2011; Trujillo et al., 2003; Williams
et al., 2011). NHEJ represents the major DSB repair pathway in
mammalian cells, repairing DSBs in all cell cycle phases (Roth-
kamm et al., 2003). HR contributes to distinct processes,
including meiotic recombination, replication fork stabilization,
and one-ended DSB repair, and overlaps with NHEJ to repair
two-ended DSBs in late S/G2 phase (Jeggo et al., 2011;
Schlacher et al., 2011). Current models in mammalian cells sug-
gest that the abundant Ku70/Ku80 heterodimer rapidly binds to
all two-ended DSBs, allowing NHEJ to make the first attempt at
DSB rejoining (Beucher et al., 2009; Shibata et al., 2011). Thus,
even in G2 where HR functions, NHEJ rejoins most DSBs but
subsequently repair switches to HR, necessitating resection
(Shibata et al., 2011). Resection of two-ended DSBs is a critical
step that initiates and potentially commits to repair by HR when
NHEJ stalls. MRE11 nuclease activities promote resection, but
their roles are unclear; furthermore, MRE11 exonuclease has
the wrong polarity to drive resection (Llorente and Symington,
2004; Stracker and Petrini, 2011).
HR (but not NHEJ) functions during meiosis. Meiotic DSBs are
introduced by Spo11, a topoisomerase II-like protein, which
bridges DNA ends; DSB opening and Spo11 removal require
Mre11 nuclease activity (Garcia et al., 2011). In yeast, DSB pro-
cessing creates a ssDNA nick up to 300 bp from the DSB end
followed by bidirectional resection. Mre11 30-50 exonuclease
activity digests toward the DSB end, and exonuclease 1 (Exo1)
generates ssDNA moving 50-30. Current data suggest that
Mre11 endonuclease activity makes the initial ss nick, with the
combined activities promoting removal of covalently end-bound
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Spo11. For HR in mitotic cells, Sae2/MRX (CtIP/MRN) initiates
DSB resection, enabling 50-30 resection by Exo1/Sgs1 (EXO1/
BLM), although further details are unclear (Mimitou and Syming-
ton, 2008; Nimonkar et al., 2011; Zhu et al., 2008).
Mre11 mutations impact either its exonuclease activity alone
or both activities or disturb Mre11 interactions with interfacing
Rad50 or Nbs1; mutations specifically impactingMre11 endonu-
clease activity have not been described (Buis et al., 2008; Wil-
liams et al., 2008, 2009, 2011). We reasoned that unraveling
the role of MRE11 nuclease activities during resection would
require the ability to specifically ablate endo- or exonuclease
activity, which in turn necessitates structural insight into regions
on MRE11 required for these activities. Mirin, a characterized in-
hibitor of MRE11 exonuclease activity, acts by an unknown
mechanism but does not disrupt the MRE11 complex (Dupre´
et al., 2008). Here we combined Mre11 structure determinations
with focusedmirin libraries to create and apply specific inhibitors
to address MRE11 nuclease roles. First, we determined Mre11
structures with bound mirin, and we exploited this insight and
focused chemical libraries to develop inhibitors that specifically
perturb MRE11 exo- or endonuclease activities. Second, we ex-
ploited these inhibitors to unravel MRE11’s role during resection
of two-ended DSBs. Our findings support a mechanism similar
to MRE11’s role during meiosis but reveal unexpected impacts
on the regulation of pathway choice.
RESULTS
Structure Determination, Analysis, and Derivation
of Specific MRE11 Inhibitors
To develop specific Mre11 endo- and exonuclease inhibitors, we
leveraged Mre11 structural data and mirin inhibitor chemistry.
We created and employed a focused chemical library of mirin
derivatives (named PFM for researchers E. Petricci, S. Forli,
and D. Moiani, who made it) with different substituents in the
styryl moiety and the pseudothiohydantoin ring replaced with a
substituted rodanin moiety to test structure activity relationship
(SARs) (Figure 1A) in concert with structural determinations of
Mre11 inhibitor complexes (Figure 1B). To define the structural
basis for mirin activity, we determined Mre11 structures with
bound mirin. As human MRE11 did not crystallize with mirin,
we exploited the high conservation of Mre11 and produced
Thermotoga maritima Mre11 (1–324) (TmMre11) (Das et al.,
2010) and cocrystallized it with bound mirin (Figures 1B, S1A,
and S1B and Table S1 available online). The Mre11 di-Mn active
site lies in a groove at the base of the capping domain, restricting
dsDNA access. Two b-a connecting loops within this groove are
positioned to interact with DNA and be regulated by Rad50: one
contains exonuclease-critical His61, and the other, Asn93, which
we propose interacts with ssDNA (TmMre11 numbering) (Lim
et al., 2011; Mo¨ckel et al., 2012; Williams et al., 2008). Our
2.3 A˚ resolution cocrystal structure suggested that mirin is posi-
tioned adjacent to His61 (equivalent to P. furiosusMRE11 His52,
S. cerevisiae His59, and human His63) (Das et al., 2010; Hopfner
et al., 2001; Lim et al., 2011; Williams et al., 2008) (Figure 1B).
This His61 site controls dsDNA end access to the geometrically
restricted active site by rotating the DNA phosphate backbone
and opening base stacking at the DNA end (Williams et al.,
2008). A similar opening of dsDNA, key for phosphate backbone
access to a dimetal ion active site, occurs in FEN1 (Tsutakawa
et al., 2011).
To test the structural implications of mirin binding, we
reasoned that we should be able to replace the hydroxyl group
in the styryl moiety, which does not interact with Mre11, with
an amino group. Indeed, structures suggested that like mirin,
analog PFM39, which has an amino group in place of the hydrox-
yl group, bound in the pocket between the His61 loop and the
adjacent loop (Asn93-Lys97) (Figures 1B, S1A, and S1B). As
for mirin, ligand binding in this site restricts phosphate rotation
for dsDNA exonuclease activity. Nuclease assays using
TmMre11 (Das et al., 2010) and human MRN confirmed in vitro
inhibition of MRE11 exonuclease activity by mirin and PFM39
(Figures 1C, S1C, and S1D). Importantly, neither compound in-
hibited TmMre11 or human MRE11/MRN endonuclease activity
on ssDNA circles (Figures 1D, S1E, and S1F).
To employ these structures to develop differential specificity,
we applied the anchored plasticity approach developed for
structure-based design of nitric oxide synthase isozyme-specific
inhibitors (Garcin et al., 2008). The Asn93 loop, flanked by the
His61 loop and a groove suitable for ssDNA binding, interacts
with a flipped out base in the Mre11-DNA hairpin complex (Pro-
tein Data Bank [PDB] ID code 3DSD). It also binds a glycerol
mimic of the phosphoribose backbone in human MRE11 (PDB
ID code 3T1I) (Park et al., 2011), and sulfate ions spanning5 nu-
cleotides lead to bound dAMP in aMre11 product complex (PDB
ID code 1II7) (Hopfner et al., 2001). Collectively, this groove pro-
vides the strongest computationally identified ssDNA-binding
site. We reasoned that the flanking His61 loop provides a likely
anchor point due to tight interactions at its ends in the dimer
interface and the active site (by hydrophobic side chains Leu59
and Leu60, and Mn ion ligand Asp58) plus close packing along
its length. We therefore designed N-alkyl mirin derivatives that
might bind against the His61 loop anchor and shift the flexible
Asn93 loop into the adjacent ssDNA-binding groove. We made
complexes and determined crystal structures with two such
N-alkylated derivatives: PFM01, which has a rhodanine ring
plus an isobutyl chain on the nitrogen, and PFM03, which has
a sec-butyl chain. Analysis of crystal structures with Mre11 re-
vealed that the addition of an N-alkyl group (Mre11 complex
with PFM01 at 2.3 A˚ and PFM03 at 2.4 A˚ resolution) caused these
inhibitors to bind in an adjacent site shifted 7 A˚ toward the
dimer interface (Figures 1B, S1A, and S1B). Yet, theN-alkyl mirin
derivatives do anchor against the His61 loop and shift the Asn93
loop into the proposed ssDNA-binding channel. Their binding
shifts residues His94-Phe102 (the loop plus start of the dimer
interface helix) to geometrically interfere with the proposed
ssDNA path to the active site metal ions (Figures 1B, S1A, and
S1B). Nuclease activity assays confirmed specific inhibition of
MRE11 endonuclease activity by PFM03, with little impact on
its exonuclease activity (Figures 1C, 1D, and S1C–S1F).
Thus, crystal structures suggested that inhibitors bind two
distinct sites of MRE11: (1) near His61 to block DNA phosphate
backbone rotation and exonuclease activity and (2) near the
dimer interface to disrupt the ssDNA-binding groove and endo-
nuclease activity. Based on nuclease activity analyses using
human MRE11 and toxicity assessment in mammalian cells,
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we focused the ensuing cellular analyses on mirin and PFM39,
which primarily inhibit MRE11 exonuclease activity, and N-alky-
lated PFM derivatives, PFM03 and PFM01, which primarily block
endonuclease activity.
MRE11 Inhibitors Prevent DSB End Resection
HR has a major role in facilitating recovery from aberrant replica-
tion events. To focus specifically on the role of MRE11 in the
interplay between HR and NHEJ at two-ended DSBs, we sought
to avoid complications from its role in replication fork stabiliza-
tion and/or recovery and employed the inhibitors to examine
repair pathway choice at DSBs generated in G2 following expo-
sure to ionizing radiation (IR).
To assess IR-induced resection at two-ended DSBs, we used
fluorescence-activated cell sorting (FACS) to quantify chro-
matin-bound RPA in G2 phase (Shibata et al., 2011). Following
10 Gy IR, we observed increased chromatin-bound RPA in con-
trol G2 cells but little change following treatment with MRE11
A C
B D
Figure 1. Development of Inhibitors against MRE11 Exo- or Endonuclease Activity
(A) Derivation by modification of mirin.
(B) TmMre11 structures in complex with exo- and endonuclease inhibitors. The top left panel shows an overlay of cocrystal structures of TmMre11 (cartoon,
colored brown) in complex with the exonuclease inhibitors, mirin (sticks, carbon atoms colored brown), and PFM39 (green). The bottom left panel shows an
overlay of the cocrystal structures of TmMre11 (cyan) in complex with the endonuclease inhibitors PFM01 (purple) and PFM03 (dark green). Each inhibitor type
has a distinct binding site in proximity to the active site metal ions. The right hand panel shows an overlay of the unliganded TmMre11 (cartoon, colored pink) with
mirin (brown) and PFM03 (cyan). The relative position of each inhibitor is highlighted by a dotted representation of its van der Waals surface. The endonuclease
and exonuclease inhibitor binding sites are adjacent, but respectively positioned to distinctly disrupt dsDNA (light green tubes) end opening by His61 or the
ssDNA (violet tube) pathway adjacent to the loop containing Asn93–Phe102, leading toward the active site metal ions. Nitrogen, oxygen, and sulfur atoms are
colored blue, red, and yellow, respectively. Active site metal ions are shown as magenta spheres.
(C) Mirin and PFM39, but not PFM03, inhibit 5 nM MRN exonuclease activity. Labeled DNA (100 nM) were incubated with human MRN for 30 min at 37C.
(D) PFM03, but not mirin or PFM39, inhibits human MRE11 endonuclease activity. Analysis using MRN in place of MRE11 is shown in Figure S1E. fX174 circular
ssDNA was incubated with purified human MRE11 and DMSO or inhibitor at the indicated concentration. The inhibition assay was established in a time and
protein concentration-dependent manner to cause loss of 70% circular DNA. The figure shows the percent of circular ssDNA degraded relative to the control
(DMSO-treated) sample. c, circular DNA; *, degraded DNA. PFM01 was excluded from inhibitor analysis due to inefficient solubility in vitro. Error bars represent
SEM from greater than three experiments. Figures S1G–S1I show the impact of the inhibitors on MRN DNA binding and ATPase activity. See also Figure S1.
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nuclease inhibitors (Figures 2A, 2B, and S2A). CtIP functionswith
MRE11 during resection; CtIP siRNA also dramatically impairs
resection (Sartori et al., 2007) (Figure 2B). Confirming an impact
on resection, ssDNA formation detected using a-bromodeoxyur-
idine (BrdU) antibody was also significantly reduced following
inhibitor treatment (Figure S2B). Inhibitor concentrations were
optimized to find the lowest concentration reducing chromatin-
bound RPA to levels similar to those in CtIP-depleted cells (Fig-
ure 2B). RAD51 loading onto resected DNA, which can be visu-
alized as RAD51 foci, represents a downstream step of HR.
Consistent with reduced resection, all inhibitors dramatically
impaired IR-induced RAD51 foci in G2 cells (Figures 2C and
S2C). For G2 immunofluorescence (IF) analysis, aphidicolin
(APH), which inhibits the replicative polymerases and blocks
progression of S phase cells into G2, was added. APH also in-
duces pan-nuclear gH2AX in S phase, allowing S phase cells
to be distinguished from G2 cells (Beucher et al., 2009; Shibata
et al., 2011). Inhibitors neither impeded MRE11 recruitment to
DSBs nor significantly diminished ataxia telangiectasia mutated
(ATM) activation, as assessed by IR-induced pS1981-ATM
formation by western blotting and phosphorylated KAP-1
(pKAP-1) foci formation (Figures 2D, S2D, and S2E). Thus, all in-
hibitors impairMRE11 resectionwithoutdisruptingotherMRNac-
tivities, supporting the observation that ATM is activated normally
in a strain expressing nuclease-dead MRE11 (Buis et al., 2008).
MRE11 Inhibitors Confer Distinct DSB Repair
Phenotypes
X-ray-induced DSB repair monitored by enumerating gH2AX foci
loss occurs with two-component kinetics in G2 phase (Beucher
et al., 2009; Shibata et al., 2011). About 80% of X-ray-induced
DSBs are repaired with fast kinetics by NHEJ; hence, NHEJ mu-
tants show a repair defect 2 hr after IR, while 20% of DSBs are
repaired with slow kinetics by HR. To investigate HR, gH2AX foci
were enumerated at 8 hr after IR, when loss of HR proteins inmu-
tants or following siRNA confers a DSB repair defect (longer
C D
A
B
Figure 2. MRE11 Inhibitors Prevent DSB End Resection
(A) MRE11 inhibitors reduce chromatin-bound RPA levels after IR. IR-induced RPA retention in A549 cells was monitored by FACS analysis at 2 hr after 10 Gy IR.
G2 cells were gated using FACSDiva software (Figure S2A).
(B) Quantification of RPA-FACS analysis using two different concentrations of inhibitor.
(C) Either exo- or endonuclease inhibitor treatment reduces IR-induced RAD51 foci formation in G2 cells. RAD51 foci were quantified in A549 cells 2 hr after 3 Gy
IR. Knockdown efficiency of CtIP and BRCA2, included as controls, is shown. Representative images are shown in Figure S2C.
(D) MRE11 recruitment to DNA damage sites is unaffected by the MRE11 inhibitors. GM05757 primary human fibroblasts were subjected to a UV microbeam.
Protein recruitment was analyzed 1 hr after the addition of each inhibitor. gH2AX is used to identify damage sites. The scale bar is 10 mm. For G2 foci analysis,
4 mMaphidicolin (APH) was added after irradiation. APH does not affect gH2AX, RPA, RAD51 foci formation, NHEJ, or HR in G2 phase cells. Full controls for using
APH in the context of repair and signaling have been undertaken (Shibata et al., 2010, 2011). Error bars represent SEM from greater than three independent
experiments. PFM01 (100 mM), PFM03 (100 mM), PFM39 (100 mM), or mirin (500 mM)were added 30min before irradiation in (A), (C), and (D). For further analysis of
ATM activation after inhibitor treatment, see Figures S2D and S2E. See also Figure S2.
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times were avoided due to mitotic progression despite incom-
plete repair; Deckbar et al., 2007). Addition of mirin or PFM39
caused a G2 repair defect at 8 hr resembling that shown by
HR-defective ATM inhibitor (ATMi)-treated or HSC62 (BRCA2-
defective) cells (Howlett et al., 2002) (Figures 3A, 3B, and S3A).
In contrast, PFM01 or PFM03 treatment allowed normal DSB
repair. None of the MRE11 inhibitors affected gH2AX foci
numbers at 2 hr after IR, suggesting that they do not affect
canonical NHEJ, the fast DSB repair process (Beucher et al.,
2009) (Figure S3B). The impact on DSB repair was confirmed
by enumerating IR-induced chromosomal breaks in G2 cells
(Figure 3C). ATM is required for the slow DSB repair component
in G1 and G2, partly to promote heterochromatin (HC) relaxation
by phosphorylating KAP-1, an HC component (Beucher et al.,
2009; Goodarzi et al., 2008). To substantiate that defective repair
is not due to a failure to promote HC relaxation, we examined
repair following KAP-1 siRNA, which alleviates the need for
ATM to effect HC relaxation (Goodarzi et al., 2008). KAP-1 deple-
tion did not relieve the repair defect caused by MRE11 exonu-
clease inhibition but overcame the defect from ATM inhibition
(Figure 3D). Collectively, these findings show that MRE11
exo- or endonuclease inhibitors confer distinct DSB repair
phenotypes.
MRE11 Endonuclease Activity Initiates Resection
to Direct Repair toward HR
CtIP siRNA prevents HR in G2 cells, but repair can proceed by
NHEJ (Shibata et al., 2011). Hence, CtIP siRNA does not cause
a DSB repair defect in G2 cells. In contrast, loss of down-
stream HR components (BRCA2 or RAD51) confers a DSB
repair defect, suggesting that CtIP licenses HR and that CtIP
itself, or an immediate downstream step (prior to RAD51
loading), commits to HR and precludes usage of NHEJ (Shi-
bata et al., 2011). Since inhibition of MRE11 endonuclease
activity does not confer a DSB repair defect, but impedes
resection, we hypothesized that MRE11 endonuclease func-
tions similarly to CtIP, i.e., by initiating HR. We reasoned that
if MRE11 endonuclease inhibition allows NHEJ to proceed, it
B
D
A C
Figure 3. Distinct Phenotypes of MRE11 Inhibitors in DSB repair
(A and B) Exonuclease, but not endonuclease, inhibitor treatment causes a DSB repair defect in G2. DSB repair in G2 (CENPF+) cells was investigated by gH2AX
foci analysis. 1BR3 (WT) hTERT were fixed and stained at 8 hr after 3 Gy IR. Inhibitors were added 30min before IR. The full time course for DSB repair is shown in
Figure S3A.
(C) DSB repair defects following inhibitor addition are consolidated by chromosomal break analysis. Irradiated G2 cells were collected at 12–16 hr after 6 Gy IR.
(D) Depletion of the HC building factor, KAP-1, does not alleviate the DSB repair defect in exonuclease inhibitor-treated cells. 1BR3 hTERT cells were subjected to
KAP-1 siRNA and irradiated with 3 Gy. KAP-1 knockdown efficiency is shown. To prevent progression of S phase cells into G2 during analysis, we added
replicative polymerase inhibitor APH in all foci assays (A, B, and D). The dots in the box plot were created using SigmaPlot 12.0 and represent outliers (>95%
or <5%) of samples. A line in each box represents the median. Error bars represent SEM from greater than three experiments. See also Figure S3.
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would overcome the requirement for BRCA2, an essential HR
protein that functions downstream of resection for G2 phase
DSB repair. BRCA2-deficient HSC62 fibroblasts show impaired
repair in G2 at 8 hr after IR (Beucher et al., 2009; Howlett et al.,
2002). Addition of PFM01 or PFM03, but not mirin, relieved this
defect, which was confirmed by chromosomal break analysis
(Figures 4A, 4B, and S4A). These results argue that inhibition
of MRE11 endonuclease activity, like depletion of CtIP, allows
the usage of NHEJ. In contrast, the exonuclease activity func-
tions downstream of this step, when there has been a commit-
ment to HR. Thus, MRE11 endonuclease inhibition allows
repair by NHEJ, but this possibility is precluded following
MRE11 exonuclease inhibition. Consistent with this model,
RAD51 foci did not form following exo- or endonuclease inhib-
itor treatment (mirin or PFM01) (Figure 4C). To substantiate
that repair occurs by NHEJ, we added PFM01 to cells lacking
XLF, an NHEJ protein, and observed an additive repair defect
similar to the impact of siRNA CtIP (Figure 4D). Examination of
DSB repair pathway usage in cells with chromosomally inte-
grated I-SceI-inducible DSBs substantiated that adding
PFM01 or PFM03 enhances NHEJ and reduces HR, whereas
PFM39 inhibits HR without significantly increasing NHEJ (Fig-
ure 4E). Addition of the inhibitors did not alter the cell cycle
distribution during analysis (Figure S4B). These data demon-
strate that both MRE endo- and exonuclease activities are
required for HR and that MRE11 endonuclease activity initiates
A
D E
B C
Figure 4. MRE11 Endonuclease Activity Commits to Homologous Recombination
(A) Addition of MRE11 endonuclease inhibitors rescues the repair defect in HR-defective cells. gH2AX foci were enumerated in 48BR (WT) and HSC62 (BRCA2-
defective) primary cells at 8 hr after 3 Gy IR. The full time course for DSB repair and cell cycle profiles is shown in Figure S4.
(B) The chromosome break defect observed in BRCA2 siRNA-treated 1BR3 (WT) hTERT was alleviated following treatment with endonuclease inhibitor.
(C) RAD51 foci formation is diminished in HSC62 (BRCA2-defective) cells with or without inhibitor treatment. RAD51 foci formationwas analyzed 2 hr after 3 Gy IR.
(D) Treatment with an endonuclease inhibitor causes an additive repair defect in XLF, but not control, cells, demonstrating NHEJ usage. gH2AX analysis was
performed in XLF-defective hTERT cells after 2 Gy IR. Cells were irradiated with 2 Gy (rather than 3 Gy) to enhance accuracy in scoring the greater number of
DSBs remaining in XLF-defective cells.
(E) Inhibitor treatment impairs HR, but endonuclease inhibitor addition only enhances NHEJ usage. PFM39 (50 mM), PFM01 (50 mM), or PFM03 (50 mM)was added
8 hr after I-SceI transfection until cell fixation. The frequency of DSB repair usage was measured using the reporter cell lines U2OS DR-GFP (HR) or H1299 dA3
(NHEJ). The percentage of repair was normalized to the DMSO-treated control. Error bars represent SEM from greater than three experiments. See also
Figure S4.
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resection, licensing repair for HR. MRE11 exonuclease activity
functions downstream when there has been a commitment
to HR.
MRE11 Endonuclease Functions Upstream
of Exonuclease Activity in HR
Our data suggest that MRE11 endonuclease initiates resection
and functions upstream of MRE11 exonuclease activity. To
test this, we examined whether inhibition of MRE11 endonu-
clease activity could relieve the need for MRE11 exonuclease
activity for DSB repair, i.e., allow NHEJ to ensue. As anticipated,
addition of PFM01 or PFM03 substantially (although not
completely) relieved the DSB repair defect conferred by mirin
or PFM39 (Figures 5A and 5B). In contrast, a repair defect re-
mained following combined addition of mirin and PFM39, but
not PFM01 + PFM03, suggesting that the impact of PFM01/
PFM03 is not explained simply by enhancing the level of
nuclease inhibition (Figure 5B). Further, RAD51 foci did not
form, and the defect was additive in XLF cells, supporting the
notion that NHEJ is utilized for DSB repair (Figures 5C and 5D).
Coaddition of PFM01 and PFM39 enhanced NHEJ usage in
the I-SceI assay, resembling that observed following endonu-
clease inhibition alone (Figure 5E). Inhibitor titrations verified
that specific inhibition of MRE11 endonuclease activity deter-
mines pathway choice rather than the magnitude of resection
(Figure S5). Collectively, these findings argue that MRE11 endo-
nuclease functions upstream of its exonuclease activity,
licensing repair by HR.
ATLD Patient Cells Can Switch to NHEJ Usage, Verifying
That MRE11 Regulates Pathway Choice
Ataxia telangiectasia-like disorder (ATLD) is a human syndrome
with hypomorphic mutations in MRE11 (Stewart et al., 1999).
We exploited a primary fibroblast from an ATLD patient
(ATLD2) to analyze DSB repair pathway choice. Consistent
with previous reports, ATLD2 cells showed significantly reduced
E
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Figure 5. MRE11 Endonuclease Functions Upstream of Exonuclease Activity in Homologous Recombination
(A and B) Endonuclease inhibitors alleviate the repair defect conferred by the exonuclease inhibitors. DSB repair was analyzed by gH2AX foci in G2 cells at 2 and
8 hr after irradiation with 3 Gy. The repair defect is only observed at 8 hr, consistent with the fact that at 2 hr, DSB repair occurs by MRE11-independent NHEJ.
(C) A defect in IR-induced RAD51 foci formation was confirmed in the presence of double-inhibitor-treated 1BR3 (WT) hTERT cells.
(D) Cells treated with MRE11 exonuclease and endonuclease inhibitors repair DSBs by NHEJ, similar to the result in cells treated with MRE11 endonuclease
inhibitor alone.
(E) HR and NHEJ repair frequency following single or combined endonuclease and exonuclease inhibitor treatment was measured by the U2OS DR-GFP (HR) or
H1299 dA3 (NHEJ) assay, as described in Figure 4E. Error bars represent SEM fromgreater than three experiments. For further evidence showing that inhibition of
MRE11 endo- and not exonuclease activity allows NHEJ usage, see Figure S5.
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MRN levels, impairing IR-induced ATM activation and signaling
(Uziel et al., 2003) (Figure 6A). Since ATLD2 cells show reduced
ATM signaling and pKAP-1 foci formation, they are, like ATM,
defective in the repair of HC DSBs (Noon et al., 2010). This role
of MRE11 is not affected by the inhibitors (Figure S6). Thus, we
relieved this role of ATLD by carrying out KAP-1 siRNA, which
constitutively relaxes HC and bypasses this function of ATM/
MRE11 (Noon et al., 2010) (Figures 6B and S6). Although
KAP-1 siRNA alleviates the DSB repair defect in G2 phase
ATLD2 cells, it does not rescue the defect in HSC62 (BRCA2-
defective) cells, demonstrating the specificity of the impact (Fig-
ure 6B). However, significantly, the impaired RPA and RAD51
foci formation in ATLD2 cells is not rescued by KAP-1 siRNA;
however, these end points are not affected in KAP-1 siRNA-
treated control cells (Figure 6C), demonstrating that (1) MRE11
is essential for resection and (2) NHEJ can proceed in ATLD cells.
HSC62 cells show normal resection, as expected, but no RAD51
loading irrespective of KAP-1 siRNA (Figure 6C). These results
are consistent with previous findings that inhibition of ATM
causes a G2 phase DSB repair defect that can be relieved by
KAP-1 siRNA (Shibata et al., 2011). Further, to consolidate the
impact of MRE11 inhibitors, we treated ATLD cells with the inhib-
itors with or without KAP-1 siRNA (Figure 6D). As expected, no
additional impact on DSB repair was observed following addition
of either exo- or endonuclease inhibitor, demonstrating that the
repair defect caused by the exonuclease inhibitor is mediated
via MRE11 inhibition. Based on our findings above, we suggest
that ATLD2 cells subjected to KAP-1 siRNA cells can utilize
NHEJ instead of HR. To consolidate this, we added a DNA-PK
inhibitor (DNA-PKi) at 3.5 hr, when most NHEJ in G2 is
completed. DNA-PKi addition prevented the rescue of DSB
repair (Figure 6E).
Thus, consistent with the notion that MRE11 endonuclease
activity functions upstream of resection, ATLD cells can utilize
NHEJ instead of HR, provided the ATM-dependent chromatin
relaxation defect is bypassed by KAP-1 siRNA. Under these
conditions, DSB repair can ensue by NHEJ. These results
therefore substantiate our findings with MRE11 inhibitors,
providing evidence that their impact is due to specific MRE11
nuclease inhibition. With the inhibitors, however, it is unneces-
sary to utilize KAP-1 siRNA since they do not inhibit ATM acti-
vation (Figure S2).
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Figure 6. Analysis of DSB repair pathway choice in MRE11-defective ATLD cells
(A) ATLD2 cells show significantly reducedMRN levels, causing impaired IR-induced ATMactivation and downstream signaling. Cells were harvested 30min after
3 Gy IR (right panel).
(B) Depletion of KAP-1 alleviates the DSB repair defect in ATLD2 cells, confirming that the repair defect is caused by impaired chromatin modification (see also
Figure S6). DSB repair in G2 cells is examined by gH2AX foci analysis after 3 Gy IR. Box plot with statistical analysis is shown in the right panel.
(C) Impaired RPA and RAD51 foci formation in ATLD2 G2 cells is not rescued by KAP-1 siRNA, demonstrating that MRE11 is essential for resection.
(D) Exo- or endonuclease inhibitor treatment shows no additive impact on DSB repair in ATLD + KAP-1 siRNA cells.
(E) The fraction rescued by KAP-1 siRNA is prevented by a DNA-PKi. DNA-PKi is added at 3.5 hr after 3 Gy IR, when most NHEJ has been completed in G2. Error
bars represent SEM from greater than three experiments.
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Combined Exonuclease Inhibition Allows DSB Repair
by NHEJ
Next, we tested whether residual resection activity in exonu-
clease inhibitor-treated cells could be attributed to EXO1/BLM-
dependent nuclease activity, since bidirectional exonuclease
digestion 30-50 by MRE11 and 50-30 by EXO1/BLMwas proposed
to promote resection during yeast meiotic recombination (Garcia
et al., 2011). Either MRE11 exonuclease activity inhibition or
depletion of EXO1/BLM reduced RPA foci formation at DSBs
(Figure 7A). Importantly, combined inhibition and depletion
caused a greater reduction, as substantiated by pRPA immuno-
blotting (Figures 7A and 7B). Examination of DSB repair by
enumerating gH2AX foci in EXO1/BLM-depleted cells with or
without PFM39 or PFM01 revealed, unexpectedly, that PFM39
relieves the repair defect caused by EXO1/BLM depletion, sug-
gesting that combined loss of exonuclease activities allows
DSB repair by NHEJ (Figure 7C). To substantiate this, we added
DNA-PKi at 3.5 hr after IR. Although DNA-PKi does not affect
DSB repair in control cells (since repair after 3.5 hr occurs by
HR), repair was significantly impaired when PFM39 was added
to EXO1/BLM siRNA-treated cells (Figures S7A and S7B).
Further, the I-SceI-based reporter assay revealed increased
NHEJ usage following EXO1/BLM siRNA + PFM39 compared
to control cells or following EXO1/BLM siRNA alone (Figure 7D).
These results suggest that neither NHEJ nor HR can proceed
following the loss of either MRE11 30-50 exonuclease or 50-30
EXO1/BLM, since ssDNA gaps arise from MRE11 or EXO1/
BLM exonuclease activity; however, loss of both exonuclease
activities allows repair by NHEJ. We suggest that the ss nick
generated by MRE11 endonuclease activity is not a barrier to
C
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Figure 7. Combined MRE11 Exonuclease 30-50 and EXO1/BLM 50-30 Loss Allows Repair Switch to NHEJ
(A) MRE11 30-50 exonuclease and EXO1/BLM 50-30, which digest in opposite directions, both contribute to IR-induced RPA foci formation. 1BR3 (WT) hTERT cells
were fixed and stained with RPA (a resection marker) and 53BP1 (a DSB marker) at 2 hr after 3 Gy IR. RPA signal intensity was measured by ImageJ. The
quantified signal intensity of RPA foci at 53BP1 foci is shown in the right panel. For each sample, 200–300 foci were analyzed.
(B) MRE11 exonuclease and EXO1/BLM activities redundantly contribute to RPA Ser4/Ser8 phosphorylation. A549 cells are harvested at 2 hr after 30 Gy IR. The
pRPA signal was quantified by ImageJ. Since phosphorylated RPA migrates distinctly to unmodified RPA migration, the pRPA signal was normalized to Ku80
instead of total RPA.
(C) Inhibition of MRE11 exonuclease activity in EXO1/BLM-depleted cells allows normal DSB repair kinetics. gH2AX foci analysis was performed in A549 cells
following EXO1/BLM siRNA with or without inhibitors after 3 Gy IR.
(D) HR and NHEJ repair frequency following EXO1/BLM siRNA alone or EXO1/BLM siRNA + PFM39 was measured by the U2OS DR-GFP (HR) or H1299 dA3
(NHEJ) assay. Error bars represent SEM from greater than three experiments.
(E) Model for repair pathway choice at two-ended DSBs in G2. (1) In WT cells, ssDNA regions are expanded byMRE11 30-50 exonuclease and EXO1/BLM ssDNA.
(2) Loss of either MRE11 30-50 exonuclease or EXO1/BLM results in a DSB repair defect since neither HR nor NHEJ can ensue. (3) The DSB repair pathway can be
switched from HR to NHEJ in the absence of CtIP, MRE11 endonuclease, or combined loss of MRE11 exonuclease + EXO1/BLM activity. See also Figure S7.
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NHEJ most likely because it can undergo repair. Thus, while
MRE11 endonuclease activity is critical in initiating resection
and directing the switch from NHEJ to HR (i.e., it licenses HR),
failure to enlarge the nick due to combined loss of MRE11 and
EXO1/BLM exonuclease activities also allows the progression
of NHEJ (Figures 7E and S7C). Thus, the generation of an ssDNA
region rather than the endonucleolytic nick is the step that pre-
vents the usage of NHEJ and therefore represents the commit-
ment step.
DISCUSSION
Understanding the regulation of pathway choice, the influence of
nucleolytic steps, and initiation of committed nuclease steps for
DSB repair is of substantial biological and medical importance
(Ciccia and Elledge, 2010). Combined structural and biochem-
ical analyses allowed us to employ a focused chemical library
to develop MRE11 exo- and endonuclease inhibitors. These
findings show that rather than binding to MRE11’s nuclease
active site, mirin and its analogs instead impede the path of
DNA toward the active site. Although positioning of exonuclease
inhibitors mirin and PFM39 is based upon weak electron density,
which does not unambiguously distinguish orientation (Fig-
ure S1), both are implicated in binding the same site, consistent
with blocking MRE11’s ability to open dsDNA for access to the
nuclease active site and causing the observed exonuclease inhi-
bition (Figure S1B). These data suggest that MRE11, like the
damage response proteins, Atl1 and FEN1, must sculpt and
open dsDNA (Tsutakawa et al., 2011; Tubbs et al., 2009). Mirin
has revealed unexpected roles for MRE11 nuclease activity,
such as processing replication forks (Schlacher et al., 2011).
Our findings using specificMRE11 endo- and exonuclease inhib-
itors provide insights into the regulation of pathway choice.
We propose a two-step mechanism for MRE11’s role in resec-
tion during HR: an upstream endonucleolytic incision step fol-
lowed by MRE11’s exonuclease activity digesting 30-50 toward
the DNA end, coupled with EXO1/BLM activity carrying out 50-
30 resection away from the end. These findings reinforce and
extend studies on HR during meiosis in yeast, similarly support-
ing a key role for MRE11 endonuclease activity upstream of its
exonuclease activity. Yet, our study reveals a unique role of
MRE11 nuclease activities in regulating DSB repair pathway
choice, with marked mechanistic differences from its role in
yeast meiosis. In meiosis, Spo11 is covalently bound to DSB
ends, necessitating its physical removal prior to repair. Further,
repair must progress by HR since Spo11 removal initiates resec-
tion. By contrast, in mitotic cells, Ku is likely bound at DSB ends,
suggesting that NHEJ acts first to try DSB repair (Dobbs et al.,
2010). If NHEJ fails, then we propose that MRE11 endonuclease
activity nicks adjacent to the DSB. Subsequently, resection pro-
ceeds bidirectionally via MRE11 30-50 and EXO1/BLM 50-30
exonuclease activities. Our model implies that endonucleolytic
incision is restricted to the 50 strand and cleaves dsDNA.
RAD50, CtIPk, or additional factors may facilitate dsDNA open-
ing to allow this directional cleavage. Ku may be subsequently
ejected from DSB ends by MRE11 nuclease activities or by pro-
teolytic degradation (Feng and Chen, 2012; Postow et al., 2008).
Additionally, the high abundance of Ku and the presence of
DNA-PKcs in mammalian cells could influence the regulation of
pathway choice between mammalian and yeast cells.
Evaluation of MRN functions is complex due to its multiple
roles, including functions at the replication fork (activating ATR
or one-ended DSB repair), which may be distinct to its roles in
two-ended DSB repair. Here, we dissected MRE11’s function
in two-ended DSB repair, excluding complications from replica-
tion. This type of specific analysis is essential to unearth the
details of MRE11’s complex roles. Our description of MRE11 in-
hibitors and their cellular impact in this specific context opens
the door for translational applications. Resection is an important
step promoting translocations that drive carcinogenesis. There
is emerging evidence that resection occurs more avidly in tumor
cells, due, at least in part, to CDK upregulation. Thus, it is likely
that these inhibitors and the ability to manipulate DSB repair
pathway choice will have biological and clinical value.
EXPERIMENTAL PROCEDURES
Exonuclease Assay
MRE11-RAD50-NBS1 was purified as described previously (Yu et al., 2012).
Exonuclease assays were performed in exonuclease buffer (25 mM MOPS
[morpholinepropanesulfonic acid; pH 7.0], 60 mM KCl, 0.2% Tween 20,
2 mM dithiothreitol [DTT], 2 mM ATP, 5 mM MnCl2). Double-stranded (ds)
DNA substrates were generated by annealing purified oligonucleotides
JYM925 (50-gggtgaacctgcaggtgggcaaagatgtcctagcaatgtaatcgtcaagctttatgcc
gt-30) and JYM945 (50-acggcataaagcttgacgattacattgctaggacatctttgcccacctg
caggttcaccc-30). MRE11-RAD50-NBS1 (MRN; 5 nM), the indicated inhibitors
(0.8 mM), and labeled DNA (100 nM) were incubated in exonuclease buffer
for 30 min at 37C, followed by deproteinization in one-fifth volume of stop
buffer (20 mM Tris-Cl [pH 7.5] and 2 mg/ml proteinase K) for 15 min at 37C.
Reactions were loaded on an 8% acrylamide/urea gel, run at 75 W for
60 min, dried onto DE81 filter paper, and autoradiographed.
Endonuclease Assays
Endonuclease assays were performed with fX174 circular ssDNA virion DNA
(New England Biolabs), and 100 ng substrate was incubated with 300 ng pu-
rified WT hMRE11 in a 20 ml reaction (30 mM Tris-HCl [pH 7.5], 1 mM DTT,
25 mM KCl, 200 ng acetylated bovine serum albumin [BSA], 0.4% DMSO,
and 5 mMMnCl2) at 37
C for 30 min with inhibitors as described. For MRN as-
says, 100 ng substrate was incubated with 400 ng protein for 45 min in a 20 ml
reaction (30 mM Tris-HCl [pH 7.5], 1 mM DTT, 25 mM KCl, 200 ng acetylated
BSA, 0.5% DMSO, and 5 mMMnCl2). Reactions were terminated by the addi-
tion of 1/10 volume of stop solution (3% SDS, 50 mM EDTA) and proteinase K
to a final concentration of 0.1 mg/ml and incubation for 10 min at 37C. The re-
action products were run in a 0.8% agarose gel (13 Tris-acetate-EDTA [TAE])
for 90 min at 100 mA. DNA was stained with Ethidium bromide and visualized
using a Typhoon 9200 scanner. Quantification was performed with Image-
Quant 5.2 software.
Protein Crystallization and Crystal Structure Determinations
Mre11 was expressed, purified, and crystallized. Diffraction data were
collected, processed, and refined as described in the Supplemental Informa-
tion. X-ray data for crystallography were collected at the Advanced Light
Source (Lawrence Berkeley National Laboratory) on SIBYLS Beamline 12.3.1
or 8.3.1. Refined structures have good statistics and geometry (Table S1).
Cell Culture and Irradiation
48BR (human primary fibroblasts), ATLD2 (primary fibroblasts), 1BR3 hTERT,
HSC62 hTERT (BRCA2-defective), and 2BN hTERT (XLF-defective) cells were
cultured in Dulbecco’s modified Eagle’s medium (DMEM) with 15% fetal calf
serum (FCS). A549 cells were cultured in minimal essential medium (MEM)
with 10% FCS. Cells were irradiated in medium using a 137Cs gamma source
(Gammacell 1000; dose rate, 7.5 Gy/min). MRE11 inhibitor concentrations
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were 500 mMmirin, 100 mM PFM39, 100 mM PFM01, and 100 mM PFM03, un-
less otherwise stated. ATM inhibitor (KU55933; 10 mM) or DNA-PKcs inhibitor
(NU7441; 10 mM) (both from Merck) were added 30 min prior to irradiation, un-
less otherwise indicated.
Immunofluorescence and Immunoblotting
Immunofluorescence staining and immunoblotting were as described previ-
ously (Shibata et al., 2011). Antibodies are listed in the Supplemental
Information.
siRNA Knockdown
siRNA transfection of 48BR, ATLD2, 1BR3 hTERT, XLF hTERT, and A549 cells
was undertaken using HiPerFect (QIAGEN). siRNA oligonucleotides for scram-
bled control, Ku80, BRCA2, EXO1, and BLM were from Dharmacon SMART-
pool siRNA, and KAP-1 siRNA is used as described (Shibata et al., 2011).
siRNA was carried out as described (Shibata et al., 2011).
Chromosomal Break Analysis
After 24 hr following BRCA2 siRNA transfection, cells were irradiated (6 Gy)
with or without inhibitors. APH (4 mM) was added 10 min before IR. Medium
was refreshed 12 hr after IR, and cells were incubated with 4 mM APH,
0.1 mg/ml colcemid, and 600 mM UCN-01, which abolishes G2/M checkpoint
arrest, 12–16 hr after IR to collect irradiated G2 cells in mitosis. Metaphase
spread and Giemsa staining were as described (Yamauchi et al., 2011).
IR-Induced RPA Retention Assay
The assay was as previously described (Shibata et al., 2011).
gH2AX, RPA, and RAD51 Foci Analysis
Foci (>800 foci/sample) were scored blindly. Unless stated otherwise, all foci
analyses represent the mean and SEM of three experiments. Usually, results
were scored by greater than two individuals. To examine IR-induced foci in
G2 cells (Figures 2C, 3A, 3B, 3D, 4A, 4C, 4D, 5A–5D, 6B–6E, and 7C), 4 mM
APH was added after irradiation. Cells were stained with gH2AX and
CENP-F (G2 marker).
Homologous Recombination and Nonhomologous End-Joining
Assay
Direct repeat (DR)-GFP U2OS (13 105 cells) or H1299 dA3-1 (1.253 105 cells)
were plated into 6-well dishes 24 hr before I-SceI transfection. I-SceI vector
(pSceI; 1.0 or 1.25 mg)was transfected byGeneJuice or NanoJuice transfection
kit (Novagen). After 8 hr,mediumwas refreshed, andDMSOorMRE11 inhibitors
were added. After 40 hr, cells were trypsinized, and GFP-positive cells were
measured by FACS (FACSCanto; BD Biosciences) with FACSDiva software.
UV Laser Track
UV microbeams were performed as described (Harding and Bristow, 2012).
Briefly, cells were treated with a 355 nm laser set at 4 mW following 10 mM
BrdU treatment for 24 hr.
Statistical Analysis
All data were derived from three or four independent experiments unless
stated. Box plot was created by SigmaPlot 12.0. Statistical significance was
determined using Student’s two-tailed t test or Mann-Whitney U test by
SigmaPlot 12.0. *p < 0.05, **p < 0.01, ***p < 0.001.
SUPPLEMENTAL INFORMATION
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